The Braves' Jurickson Profar is reportedly facing a 162-game suspension from Major League Baseball, a significant blow to the team's 2026 season. This suspension comes as a result of Profar testing positive for a performance-enhancing drug for the second time in a year, a violation that will also render him ineligible for the postseason and cost him his entire $15 million salary. The news has left fans and analysts alike in shock, especially considering Profar's recent performance and the Braves' decision to sign him to a three-year, $42 million contract before the 2025 season. Profar's suspension began in 2025 after just four games with the Braves, when he tested positive for human chorionic gonadotropin, a hormone typically produced during pregnancy. This suspension is a stark reminder of the strict penalties imposed by MLB for second PED violations, with Profar becoming just the sixth player to face such a punishment. The Braves, while expressing disappointment, have stated their support for Profar, hoping he learns from this experience. With Profar's future in question, the Braves must now adapt to life without their designated hitter, who was expected to be a key part of their lineup in 2026. The suspension also means Profar will miss the World Baseball Classic, where he was set to represent the Netherlands. This latest development raises questions about the effectiveness of MLB's PED policies and the potential consequences for players and teams alike.
